Literature DB >> 24354957

The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence.

S Meisgen1, T Östberg, S Salomonsson, B Ding, H Eliasson, A Mälarstig, L Alfredsson, L Klareskog, A Hamsten, T Olsson, T Axelsson, F Gadler, A Jonzon, S-E Sonesson, I Kockum, M Wahren-Herlenius.   

Abstract

OBJECTIVE: The main aim of this study was to identify foetal susceptibility genes on chromosome six for Ro/SSA autoantibody-mediated congenital heart block. SUBJECTS AND
DESIGN: Single nucleotide polymorphism (SNP) genotyping of individuals in the Swedish Congenital Heart Block (CHB) study population was performed. Low-resolution HLA-A, -Cw and -DRB1 allele typing was carried out in 86 families comprising 339 individuals (86 Ro/SSA autoantibody-positive mothers, 71 fathers, 87 CHB index cases and 95 unaffected siblings).
RESULTS: A case-control comparison between index cases and population-based out-of-study controls (n = 1710) revealed association of CHB with 15 SNPs in the 6p21.3 MHC locus at a chromosome-wide significance of P < 2.59 × 10(-6) (OR 2.21-3.12). In a family-based analysis of association of SNP markers as well as distinct MHC class I and II alleles with CHB, HLA-DRB1*04 and HLA-Cw*05 variants were significantly more frequently transmitted to affected individuals (P < 0.03 and P < 0.05, respectively), whilst HLA-DRB1*13 and HLA-Cw*06 variants were significantly less often transmitted to affected children (P < 0.04 and P < 0.03). We further observed marked association of increased paternal (but not maternal) HLA-DRB1*04 transmission to affected offspring (P < 0.02).
CONCLUSIONS: HLA-DRB1*04 and HLA-Cw*05 were identified as novel foetal HLA allele variants that confer susceptibility to CHB in response to Ro/SSA autoantibody exposure, whilst DRB1*13 and Cw*06 emerged as protective alleles. Additionally, we demonstrated a paternal contribution to foetal susceptibility to CHB for the first time.
© 2013 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  HLA-DRB1*04; MHC; autoantibodies; congenital heart block; neonatal lupus erythematosus

Mesh:

Substances:

Year:  2014        PMID: 24354957     DOI: 10.1111/joim.12179

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  5 in total

1.  Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Authors:  Hannah C Ainsworth; Miranda C Marion; Tiziana Bertero; Antonio Brucato; Rolando Cimaz; Nathalie Costedoat-Chalumeau; Micaela Fredi; Patrick Gaffney; Jennifer Kelly; Kateri Levesque; Alice Maltret; Nathalie Morel; Veronique Ramoni; Amelia Ruffatti; Carl D Langefeld; Jill P Buyon; Robert M Clancy
Journal:  Arthritis Rheumatol       Date:  2017-10-17       Impact factor: 10.995

Review 2.  The clinical spectrum of autoimmune congenital heart block.

Authors:  Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

Review 3.  Autoimmune-associated Congenital Heart Block: A New Insight in Fetal Life.

Authors:  Kai-Yu Zhou; Yi-Min Hua
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

4.  Environmental and lifestyle factors influencing risk of congenital heart block during pregnancy in anti-Ro/SSA-positive women.

Authors:  Sabrina Meisgen; Joanna Tingström; Amanda Skog Andreasson; Sven-Erik Sonesson; Ingrid Kockum; Marie Wahren-Herlenius
Journal:  RMD Open       Date:  2017-09-07

5.  Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function.

Authors:  Sabrina Meisgen; Malin Hedlund; Aurelie Ambrosi; Lasse Folkersen; Vijole Ottosson; David Forsberg; Gudny Ella Thorlacius; Luca Biavati; Linn Strandberg; Johannes Mofors; Daniel Ramskold; Sabrina Ruhrmann; Lauro Meneghel; William Nyberg; Alexander Espinosa; Robert Murray Hamilton; Anders Franco-Cereceda; Anders Hamsten; Tomas Olsson; Lois Greene; Per Eriksson; Kristina Gemzell-Danielsson; Stina Salomonsson; Vijay K Kuchroo; Eric Herlenius; Ingrid Kockum; Sven-Erik Sonesson; Marie Wahren-Herlenius
Journal:  Ann Rheum Dis       Date:  2022-04-25       Impact factor: 27.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.